Cat No.
CEI-1096
Description
Ki20227, a c-fms tyrosine kinase inhibitor, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.
Abbr
Ki20227(CSF1R)
Alias
C-FMS, CD115, CSF-1R, CSFR, FIM2, FMS, HDLS, M-CSF-R
Synonyms
C-FMS, CD115, CSF-1R, CSFR, FIM2, FMS, HDLS, M-CSF-R
CAS No.
623142-96-1
Product_Overview
c-fms tyrosine kinase inhibitor
Targets
c-Fms
Chemical Name
(N-{4-[(6,7-dimethoxy-4-quinolyl)oxy]-2-methoxyphenyl}-N'-[1-(1,3-thiazole-2-yl)ethyl]urea)
M.Wt
480.54
Purity
> 95%
Solubility
DMSO > 112mg/mL Water >1mg/mL Ethanol > 4mg/mL
Storage
4 centigrade
Stability
2 years -20 centigrade Powder
1 month -4 centigrade in DMSO
More than one month -80 centigrade in DMSO
